Extracorporeal Carbon Dioxide Removal to De-escalate Venovenous Extracorporeal Membrane Oxygenation in Severe COVID-19 Acute Respiratory Distress Syndrome

In a subset of patients with severe COVID acute respiratory distress syndrome (ARDS) there was a need for extracorporeal membrane oxygenation (ECMO) for pulmonary support. The primary extracorporeal support tool for severe COVID ARDS is venovenous (VV) ECMO, however after hypoxemic respiratory failure resolves many patients experience refractory residual hypercarbic respiratory failure. Extracorporeal Carbon Dioxide Removal (ECCO2R) for isolated hypercarbic type II respiratory failure can be used in select cases to deescalate patients from VV ECMO while the lung recovers the ability to exchange CO2.

Source: Journal of Cardiothoracic and Vascular Anesthesia - December 20, 2023 Category: Anesthesiology Authors: Gaetano Cambria, Audrey E. Spelde, Salim E. Olia, Mauer Biscotti, Emily Mackay, Michael Ibrahim, Marisa Cevasco, Christian Bermudez, William Vernick, Jacob Gutsche, Asad A. Usman Tags: Original Article Source Type: research